Exostat Medical
Exostat Medical creates MicroStat Systems, a device for systemic monitoring of oral mucosa CO2 levels.
Founded
2008Exostat Medical creates MicroStat Systems, a device for systemic monitoring of oral mucosa CO2 levels.
Exostat Medical was founded with the mission to revolutionize systemic monitoring through innovative, non-invasive technology. The company's core product, the MicroTrend™ System, measures the partial pressure of carbon dioxide in the oral mucosal tissue (POMCO2). This device aims to address the critical healthcare challenge of early detection of hypoperfusion, a condition where inadequate delivery of oxygen and nutrients to body tissues can lead to organ failure and death. Exostat Medical focuses on providing healthcare providers with advanced tools for early diagnosis and intervention.
Notable figures associated with Exostat Medical include its founding team of medical and technology experts, though specific names are not provided. The company has attracted attention from investors interested in cutting-edge medical technologies. Key achievements include the development and deployment of the MicroTrend™ System, which has the potential to significantly impact patient outcomes by enabling timely medical responses to hypoperfusion. Overall, Exostat Medical's innovative approach has positioned it as a promising player in the healthcare technology market.
Companies similar to Exostat Medical include Eso Technologies, Exhalix, Exo and Twin Star ECS.
Exostat Medical was founded in 2008.
Exostat Medical's headquarters is located in Prior Lake, MN, US.
Exostat Medical's most recent funding round was for $565k (USD) in August 2012.
As of Aug 1, 2012, Exostat Medical has disclosed funding of $2.4M (USD). Undisclosed round amounts are excluded.
Exostat Medical has 30 employees as of Feb 5, 2024.
Twin Star ECS
